Progression through the S phase of the cell cycle is controlled by cyclin-dependent kinase 2 (CDK2), the activity of which depends on its binding to regulatory partners (cyclins E and A). Deregulation of the activity of CDK2 has been associated with several types of sickness, such as infectious, neurodegenerative, and proliferative diseases. Based on these data, CDK2 has become an attractive target for the development of new anticancer drugs. Indoledione derivatives have recently received special attention in virtue of their pronounced biological e ff ects, such as antiproliferative, antioxidant and antimicrobial properties. In the present work we have investigated the antiproliferative e ff ect of an indolone-based derivative, namely DPIT, whose synthesis we have recently reported, with the aim to clarify its mechanism of action. Furthermore, docking studies have been performed on the eight stereoisomers of DPIT to investigate their capacity to interact as a ligand with ortho - or allosteric sites of CDK2. The encouraging results showed DPIT as a promising candidate for a new type 3 class of inhibitors of CDK2 that recognize the allosteric site

Decorated 6,60,7,70-tetrahydro-1H,10H-2,30-biindole scaffold as promising candidate for recognition of the CDK2 allosteric site

SCALA, ANGELA;SCIORTINO, Maria Teresa;COLAO, IVANA;SIRACUSANO, GABRIEL;GRASSI, Giovanni
2015-01-01

Abstract

Progression through the S phase of the cell cycle is controlled by cyclin-dependent kinase 2 (CDK2), the activity of which depends on its binding to regulatory partners (cyclins E and A). Deregulation of the activity of CDK2 has been associated with several types of sickness, such as infectious, neurodegenerative, and proliferative diseases. Based on these data, CDK2 has become an attractive target for the development of new anticancer drugs. Indoledione derivatives have recently received special attention in virtue of their pronounced biological e ff ects, such as antiproliferative, antioxidant and antimicrobial properties. In the present work we have investigated the antiproliferative e ff ect of an indolone-based derivative, namely DPIT, whose synthesis we have recently reported, with the aim to clarify its mechanism of action. Furthermore, docking studies have been performed on the eight stereoisomers of DPIT to investigate their capacity to interact as a ligand with ortho - or allosteric sites of CDK2. The encouraging results showed DPIT as a promising candidate for a new type 3 class of inhibitors of CDK2 that recognize the allosteric site
File in questo prodotto:
Non ci sono file associati a questo prodotto.
Pubblicazioni consigliate

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11570/2914968
 Attenzione

Attenzione! I dati visualizzati non sono stati sottoposti a validazione da parte dell'ateneo

Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 7
  • ???jsp.display-item.citation.isi??? 7
social impact